AG
EGRX

Aperio Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Aperio Group’s Portfolio EGRX Stock Details EGRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$493K Buy
2020
Q3 		$330K Buy
2020
Q2 		$297K Buy
2019
Q3 		– Sell
2019
Q2 		$105K Buy
2017
Q3 		– Sell
2017
Q2 		$282K Buy